Ani Mebalds/LinkedIn
Oct 24, 2026, 05:39
Ani Mebalds: Advancing the Availability of Cryopreserved Blood Products at AABB
Ani Mebalds, Science Team Lead at Vitrafy Life Sciences, shared a post on LinkedIn:
“That’s a wrap on an incredible three days of learning, networking and collaboration at AABB in Atlanta.
It’s inspiring to connect with so many brilliant minds, hear about the latest innovations, and see the progress being made towards improving the availability of cryopreserved blood products.
It’s exciting to be part of an industry pushing the boundaries of what’s possible, and to contribute to work that has the potential to make a meaningful difference for patients and clinical practice.
Thank you to everyone who shared their knowledge, ideas and enthusiasm. Looking forward to what’s next!”
Stay updated with Hemostasis Today.
-
Oct 24, 2026, 05:46James Posada: Demonstrating the Benefits of Nuclease Therapy in Ischemic Stroke
-
Oct 24, 2026, 05:44Juan Luis Fernández Masip: Reconnecting With the Australia and New Zealand Hematology Community at Blood 2026
-
Oct 24, 2026, 05:43No One Should Navigate Von Willebrand Disease Alone – EHC
-
Oct 24, 2026, 05:42Joseph R. Shaw: Thrombin Generation as a Tool for Coagulation Phenotyping in Critically Ill Patients
-
Oct 23, 2026, 17:45Lucy Brook: Had the Privilege of Attending the Blood 2026 Conference with New Zealand Blood Service
-
Oct 23, 2026, 16:05Platelet Secretion Defects and Their Role in the Diagnosis of Bleeding Disorders
-
Oct 23, 2026, 16:00Hemophilia Alliance team in New Orleans at the ATHN Data Summit
-
Oct 23, 2026, 15:49Brian Sapp: Why Exact Calf Vein Naming Is Critical for DVT Diagnosis?
-
Oct 23, 2026, 15:33Smitirupa Mishra: A Systematic Approach to Bone Marrow Examination